A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Healthy
Interventions
DRUG

Dexamethasone Ophthalmic

Insertion Device: A handheld mechanical device used by the clinician to dilate the punctum and deliver the DEXTENZA insert into the canaliculus; designed to be single-use and pre-loaded with a single DEXTENZA insert.

DEVICE

Dilator

Intracanalicular Dilator Device

Trial Locations (1)

57108

Ocular Therapeutix, Inc., Sioux Falls

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY